Industry: Pharmaceuticals, Biotechnology
Founded in 2003, Tengion is a leader in developing autologous neo-organs and tissues, such as bladders, that are derived from the patient’s own (autologous) cells. Tengion’s proprietary approach to regenerative medicine has the potential to enable people with organ and tissue failure to lead healthier lives without donor transplants or the side effects of current therapies. ( www.tengion.com )
Tengion , Inc.
2200 Renaissance Boulevard Suite 150
King Of Prussia, Pennsylvania 19406
USA
Tel: (610) 292-8364
Fax: (610) 275-3754